"","traits"
"1","celiac disease"
"2","endometriosis"
"3","malaria"
"4","lung carcinoma"
"5","MHPG measurement"
"6","thyroxine measurement"
"7","antioxidant measurement"
"8","arm span"
"9","CCL5 measurement"
"10","energy expenditure"
"11","fatty acid measurement"
"12","folic acid measurement"
"13","gestational age"
"14","head circumference"
"15","IGFBP-1 measurement"
"16","metabolic rate measurement"
"17","urinary metabolite measurement"
"18","amino acid measurement"
"19","body composition measurement"
"20","energy intake"
"21","physical activity"
"22","response to perphenazine"
"23","cardiac troponin T measurement"
"24","cataract"
"25","cognitive decline"
"26","hypertrophic cardiomyopathy"
"27","lean body mass"
"28","lipoprotein measurement"
"29","otitis media"
"30","pancreatitis"
"31","platelet reactivity measurement"
"32","response to methotrexate"
"33","response to tamsulosin"
"34","response to temozolomide"
"35","serum IgM measurement"
"36","visceral Leishmaniasis"
"37","response to opiate"
"38","erythrocyte measurement"
"39","response to quetiapine"
"40","response to risperidone"
"41","response to ziprasidone"
"42","suicidal ideation"
"43","von Willebrand factor measurement"
"44","Sneeze"
"45","braces"
"46","left atrial function"
"47","left ventricular function"
"48","thyroid function"
"49","cardiovascular measurement"
"50","longevity"
"51","blood viscosity"
"52","anthropometric measurement"
"53","blood sedimentation"
"54","erythrocyte count"
"55","erythrocyte indices"
"56","cortisol measurement"
"57","response to dietary antigen"
"58","hemoglobin A2 measurement"
"59","cryoglobulinemia"
"60","serum lipase activity measurement"
"61","emphysema pattern measurement"
"62","height-adjusted body mass index"
"63","Heschl's gyrus morphology measurement"
"64","pneumoconiosis"
"65","response to silica exposure"
"66","allergic rhinitis"
"67","osteoarthritis biomarker measurement"
"68","sensory perception of sound"
"69","visual perception"
"70","ossification of the posterior longitudinal ligament of the spine"
"71","generalised epilepsy"
"72","osteoprotegerin measurement"
"73","recombination measurement"
"74","FEV change measurement"
"75","esophageal squamous cell carcinoma"
"76","binge eating"
"77","overweight body mass index status"
"78","underweight body mass index status"
"79","longitudinal BMI measurement"
"80","congenital left-sided heart lesions"
"81","parental genotype effect measurement"
"82","psychotic symptoms"
"83","mammographic density measurement"
"84","chemotherapy-induced hypertension"
"85","response to bevacizumab"
"86","cumulative dose response to bevacizumab"
"87","reading"
"88","Vogt-Koyanagi-Harada disease"
"89","antinuclear antibody measurement"
"90","sum of skinfolds"
"91","neonate"
"92","plasma plasminogen measurement"
"93","family size"
"94","hypospadias"
"95","Myopia"
"96","age-related cataract"
"97","mitochondrial DNA measurement"
"98","response to high-dose melphalan"
"99","thiopurine immunosuppressant-induced pancreatitis"
"100","infant expressive language ability"
"101","response to thiopurine"
"102","HIV viral set point measurement"
"103","susceptibility to viral and mycobacterial infections"
"104","antidepressant-induced side effect"
"105","antidepressant-induced dizziness"
"106","antidepressant-induced sexual dysfunction"
"107","antidepressant-induced visual impairment"
"108","antidepressant-induced hearing impairment"
"109","response to bupropion"
"110","response to buspirone"
"111","response to citalopram"
"112","response to sertraline"
"113","response to venlafaxine"
"114","selenium measurement"
"115","serum iron measurement"
"116","transferrin saturation measurement"
"117","total iron binding capacity"
"118","systolic blood pressure"
"119","diastolic blood pressure"
"120","response to allopurinol"
"121","smooth surface dental caries"
"122","mean arterial pressure"
"123","transferrin measurement"
"124","inflammatory marker measurement"
"125","chronic bronchitis"
"126","gastritis"
"127","medication adherence behavior"
"128","response to phenytoin"
"129","severe cutaneous adverse reaction"
"130","pulmonary artery enlargement"
"131","laryngeal squamous cell carcinoma"
"132","carotid plaque build"
"133","mammographic density percentage"
"134","dense area measurement"
"135","non-dense area measurement"
"136","hepatic lipid content measurement"
"137","angiographic measurement"
"138","Kashin-Beck disease"
"139","Herpes Zoster"
"140","cotinine glucuronidation measurement"
"141","nicotine glucuronidation measurement"
"142","hereditary hemochromatosis"
"143","Alzheimer's disease biomarker measurement"
"144","angiotensin-converting enzyme measurement"
"145","superior frontal gyrus grey matter volume measurement"
"146","interferon alpha measurement"
"147","response to losartan"
"148","MMR-related febrile seizures"
"149","febrile seizures"
"150","hypokalemia"
"151","carbon monoxide exhalation measurement"
"152","calcium intake measurement"
"153","L-arginine measurement"
"154","asymmetrical dimethylarginine measurement"
"155","symmetrical dimethylarginine measurement"
"156","cigarettes per day measurement"
"157","pack-years measurement"
"158","smoking status measurement"
"159","drug-induced agranulocytosis"
"160","coffee consumption measurement"
"161","cups of coffee per day measurement"
"162","psychosocial stress measurement"
"163","body height at birth"
"164","infant body height"
"165","anxiety disorder"
"166","typhoid fever"
"167","vascular brain injury"
"168","Lewy body dementia"
"169","cerebrospinal fluid biomarker measurement"
"170","left inferior lateral ventricle volume measurement"
"171","serum VEGFR2 concentration measurement"
"172","neurofibrillary tangles measurement"
"173","neuritic plaque measurement"
"174","vascular brain injury measurement"
"175","Alzheimer's disease neuropathologic change"
"176","senile plaques"
"177","response to red blood cell transfusion"
"178","alloimmunization"
"179","word list delayed recall measurement"
"180","paragraph delayed recall measurement"
"181","docosapentaenoic acid measurement"
"182","oleic acid measurement"
"183","arachidonic acid measurement"
"184","linoleic acid measurement"
"185","glucose tolerance test"
"186","leukocyte count"
"187","platelet count"
"188","partial thromboplastin time"
"189","heart function measurement"
"190","vital capacity"
"191","forced expiratory volume"
"192","drinking behavior"
"193","smoking behavior"
"194","smoking cessation"
"195","lentiform nucleus measurement"
"196","attempted suicide"
"197","mental process"
"198","blood pressure"
"199","heart rate"
"200","electrocardiography"
"201","exercise test"
"202","alcohol drinking"
"203","coffee consumption"
"204","tooth eruption"
"205","episodic memory"
"206","short-term memory"
"207","speech perception"
"208","intelligence"
"209","body weight"
"210","bulimia nervosa"
"211","cervical carcinoma"
"212","response to dabigatran etexilate"
"213","aspirin hydrolysis measurement"
"214","brain connectivity measurement"
"215","response to carboplatin"
"216","glomerular filtration rate"
"217","oligoclonal band measurement"
"218","body height"
"219","body mass index"
"220","body fat distribution"
"221","waist circumference"
"222","waist-hip ratio"
"223","birth weight"
"224","corneal topography"
"225","neuroimaging measurement"
"226","hematocrit"
"227","reasoning"
"228","resting heart rate"
"229","mortality"
"230","circadian rhythm"
"231","sensory perception of taste"
"232","electroencephalogram measurement"
"233","event-related brain oscillation"
"234","psychomotor performance"
"235","information processing speed"
"236","personality trait"
"237","c-reactive protein measurement"
"238","ferritin measurement"
"239","soluble transferrin receptor measurement"
"240","iron biomarker measurement"
"241","PR interval"
"242","angiotensin converting enzyme activity measurement"
"243","brain measurement"
"244","fasting blood glucose measurement"
"245","fasting blood insulin measurement"
"246","insulin measurement"
"247","glucose measurement"
"248","adiponectin measurement"
"249","hematological measurement"
"250","serum hepcidin measurement"
"251","telomere length"
"252","monocyte early outgrowth colony forming unit"
"253","D dimer measurement"
"254","spine bone size"
"255","hemoglobin measurement"
"256","hpv seropositivity"
"257","femoral neck bone geometry"
"258","bone measurement"
"259","bone fracture related measurement"
"260","arterial stiffness measurement"
"261","serum creatinine measurement"
"262","soluble p-selectin measurement"
"263","icam-1 measurement"
"264","sensory perception of bitter taste"
"265","mean corpuscular volume"
"266","mean corpuscular hemoglobin"
"267","lipid measurement"
"268","triglyceride measurement"
"269","urate measurement"
"270","serum gamma-glutamyl transferase measurement"
"271","alkaline phosphatase measurement"
"272","creatine kinase measurement"
"273","serum albumin measurement"
"274","neonatal systemic lupus erthematosus"
"275","chronic fatigue syndrome"
"276","a1c measurement"
"277","brain serotonin transporter measurement"
"278","bilirubin measurement"
"279","butyrylcholinesterase measurement"
"280","C4BP measurement"
"281","chemerin measurement"
"282","total cholesterol measurement"
"283","e-selectin measurement"
"284","fetal hemoglobin measurement"
"285","infant head circumference"
"286","homocysteine measurement"
"287","serum IgE measurement"
"288","interleukin 18 measurement"
"289","liver enzyme measurement"
"290","serum alanine aminotransferase measurement"
"291","mean platelet volume"
"292","naphthyl-keratin adduct measurement"
"293","lymphocyte count"
"294","brachial circumference"
"295","childhood onset asthma"
"296","gestational diabetes"
"297","eosinophilic esophagitis"
"298","hiv mother to child transmission"
"299","diabetes mellitus type 2 associated cataract"
"300","acute graft vs. host disease"
"301","gallbladder neoplasm"
"302","duodenal ulcer"
"303","acute lung injury"
"304","low density lipoprotein cholesterol measurement"
"305","high density lipoprotein cholesterol measurement"
"306","apolipoprotein a 1 measurement"
"307","osteoarthritis of the knee"
"308","cystatin c measurement"
"309","vitamin K measurement"
"310","factor VII measurement"
"311","vitamin B12 measurement"
"312","vitamin B6 measurement"
"313","sphingolipid measurement"
"314","fibrinogen measurement"
"315","prostate specific antigen measurement"
"316","progranulin measurement"
"317","igfbp-3 measurement"
"318","vitamin D measurement"
"319","nevus count"
"320","protein c measurement"
"321","coagulation factor measurement"
"322","leptin receptor measurement"
"323","phospholipid measurement"
"324","haptoglobin measurement"
"325","white matter integrity"
"326","cortisol secretion measurement"
"327","TPE interval measurement"
"328","response to vaccine"
"329","response to platinum based chemotherapy"
"330","response to ximelagatran"
"331","response to tnf antagonist"
"332","biological variation design"
"333","beta-amyloid 1-42 measurement"
"334","QT interval"
"335","tumor necrosis factor-alpha measurement"
"336","hip geometry"
"337","testosterone measurement"
"338","dihydrotestosterone measurement"
"339","familial hypercholesterolemia"
"340","serum IgA measurement"
"341","facial neural processing"
"342","vaspin measurement"
"343","Barrett's esophagus"
"344","post-traumatic stress disorder"
"345","squamous cell carcinoma"
"346","hepatitis C infection"
"347","neuropathy"
"348","blood urea nitrogen measurement"
"349","response to paclitaxel"
"350","temperament and character inventory"
"351","response to vitamin"
"352","sex hormone-binding globulin measurement"
"353","metamphetamine dependence"
"354","age at menopause"
"355","hypothyroidism"
"356","infantile hypertrophic pyloric stenosis"
"357","nodular sclerosis Hodgkin lymphoma"
"358","FEV/FEC ratio"
"359","sexual dysfunction"
"360","mri defined brain infarct"
"361","vasuclar dementia"
"362","prion disease"
"363","coronary artery calcification"
"364","carotid-femoral pulse wave velocity"
"365","metabolite measurement"
"366","hormone measurement"
"367","eye measurement"
"368","anti-cyclic citrullinated peptide antibody measurement"
"369","carotenoid measurement"
"370","tocopherol measurement"
"371","circulating cell free dna measurement"
"372","facial morphology"
"373","carbohydrate measurement"
"374","lysine measurement"
"375","N-glycan measurement"
"376","leptin measurement"
"377","matrix metalloproteinase measurement"
"378","nt-probnp measurement"
"379","lipoprotein-associated phospholipase a(2) measurement"
"380","protein measurement"
"381","CCL2 measurement"
"382","t-tau measurement"
"383","uric acid measurement"
"384","vascular endothelial growth factor measurement"
"385","p-tau measurement"
"386","adipose tissue measurement"
"387","ovarian reserve"
"388","visual cortical surface area measurement"
"389","early onset hypertension"
"390","toxic epidermal necrolysis"
"391","alcohol and nicotine codependence"
"392","alcohol withdrawal"
"393","self rated health"
"394","chaos measure"
"395","behavior or behavioral disorder measurement"
"396","self reported educational attainment"
"397","south texas assessment of neurocognition"
"398","atrial natriuretic factor measurement"
"399","CD40 ligand measurement"
"400","tissue plasminogen activator measurement"
"401","plasminogen activator inhibitor 1 measurement"
"402","response to fenofibrate"
"403","skin sensitivity to sun"
"404","copy number variation"
"405","type ii diabetes mellitus"
"406","age-related macular degeneration"
"407","multiple myeloma"
"408","cirrhosis of liver"
"409","coronary heart disease"
"410","prostate carcinoma"
"411","cardiac hypertrophy"
"412","osteoarthritis"
"413","parkinson's disease"
"414","aids dementia"
"415","chronic childhood arthritis"
"416","insulin resistance"
"417","pancreatic carcinoma"
"418","peripartum cardiomyopathy"
"419","atopy"
"420","systemic lupus erythematosus"
"421","thyroid carcinoma"
"422","esophageal carcinoma"
"423","non-small cell lung carcinoma"
"424","kidney disease"
"425","non-alcoholic fatty liver disease"
"426","pick disease"
"427","peripheral neuropathy"
"428","essential tremor"
"429","heart failure"
"430","ankle brachial index"
"431","asperger syndrome"
"432","autism"
"433","unipolar depression"
"434","vitamin D deficiency"
"435","inflammatory bowel disease"
"436","nicotine dependence"
"437","diabetic retinopathy"
"438","visceral adipose tissue measurement"
"439","psoriatic arthritis"
"440","Behcet's disease"
"441","carotid artery disease"
"442","skin pigmentation"
"443","dental caries"
"444","migraine disorder"
"445","alcohol dependence"
"446","inflammatory response"
"447","pain"
"448","kidney stone"
"449","mental retardation"
"450","rhabdomyolysis"
"451","mouth neoplasm"
"452","surfactant protein D measurement"
"453","brain aneurysm"
"454","osteoporosis"
"455","chronic kidney disease"
"456","multiple sclerosis"
"457","attention deficit hyperactivity disorder"
"458","functional laterality"
"459","drug dependence"
"460","pulmonary function measurement"
"461","stomach neoplasm"
"462","ankylosing spondylitis"
"463","Abnormality of refraction"
"464","atherosclerosis"
"465","bone density"
"466","hair color"
"467","neuropsychological test"
"468","Fuchs endothelial corneal dystrophy"
"469","personality"
"470","eye color"
"471","seasonal allergic rhinitis"
"472","sunburn"
"473","cleft lip"
"474","freckles"
"475","open-angle glaucoma"
"476","androgenetic alopecia"
"477","alopecia areata"
"478","basal cell carcinoma"
"479","IgA glomerulonephritis"
"480","hepatitis B infection"
"481","pathological myopia"
"482","vitiligo"
"483","gallstones"
"484","hypertriglyceridemia"
"485","keloid"
"486","otosclerosis"
"487","abdominal aortic aneurysm"
"488","anorexia nervosa"
"489","conduct disorder"
"490","chronic hepatitis C infection"
"491","Attached earlobe"
"492","astigmatism"
"493","coronary restenosis"
"494","coronary vasospasm"
"495","creutzfeldt jacob disease"
"496","dengue hemorrhagic fever"
"497","drug-induced liver injury"
"498","dupuytren contracture"
"499","endometrial neoplasm"
"500","erectile dysfunction"
"501","exfoliation syndrome"
"502","focal segmental glomerulosclerosis"
"503","hearing loss"
"504","heroin dependence"
"505","obsessive-compulsive disorder"
"506","carcinoid tumor"
"507","response to antimicrotubule agent"
"508","response to doxorubicin"
"509","response to epirubicin"
"510","response to etoposide"
"511","dermatomyositis"
"512","Esophageal adenocarcinoma"
"513","cocaine dependence"
"514","follicle stimulating hormone measurement"
"515","orthostatic hypotension"
"516","sex ratio"
"517","perception of facial expression"
"518","anti-neutrophil antibody associated vasculitis"
"519","economic and social preference"
"520","response to irinotecan"
"521","RR interval"
"522","optic disc size measurement"
"523","neutrophil count"
"524","nitric oxide exhalation measurement"
"525","triple-negative breast cancer"
"526","thrombin generation potential measurement"
"527","cholelithiasis"
"528","frontal theta oscillation measurement"
"529","response to candesartan"
"530","male fertility"
"531","formal thought disorder"
"532","asbestos exposure measurement"
"533","short sleep"
"534","l lactate dehydrogenase measurement"
"535","fructose-bisphosphate aldolase measurement"
"536","interleukin-6 measurement"
"537","interleukin-8 measurement"
"538","interstitial lung disease"
"539","mucocutaneous lymph node syndrome"
"540","mood disorder"
"541","migraine with aura"
"542","chronic hepatitis B infection"
"543","Wegener's granulomatosis"
"544","allergy"
"545","non-word reading"
"546","allergic sensitization measurement"
"547","axial length measurement"
"548","contact dermatitis due to nickel"
"549","molar-incisor hypomineralization"
"550","callous-unemotional behaviour"
"551","Post-operative sensory disturbance"
"552","mesothelioma"
"553","response to angiotensin-converting enzyme inhibitor"
"554","B-cell acute lymphoblastic leukemia"
"555","invasive lobular carcinoma"
"556","acne"
"557","spinal fracture"
"558","maximal midexpiratory flow rate"
"559","torsades de pointes"
"560","response to high sodium diet"
"561","response to low sodium diet"
"562","response to dietary potassium supplementation"
"563","response to cold pressor test"
"564","response to antihypertensive drug"
"565","psychosis"
"566","pyroglutamine measurement"
"567","fat body mass"
"568","tooth agenesis"
"569","schizoaffective disorder"
"570","joint damage measurement"
"571","airway hyperresponsiveness"
"572","serum alpha-1-antitrypsin measurement"
"573","serum ST2 measurement"
"574","response to mTOR inhibitor"
"575","contrast sensitivity measurement"
"576","grey matter volume measurement"
"577","serum homoarginine measurement"
"578","skin aging"
"579","adolescent idiopathic scoliosis"
"580","dyslexia"
"581","language impairment"
"582","social communication impairment"
"583","borderline personality disorder symptom"
"584","nicotine use"
"585","illegal drug consumption"
"586","non-substance related disinhibited behaviour"
"587","Mesial temporal lobe epilepsy with hippocampal sclerosis"
"588","interleukin-1 beta measurement"
"589","alpha globulin measurement"
"590","obesity"
"591","ovarian carcinoma"
"592","sporadic amyotrophic lateral sclerosis"
"593","type i diabetes mellitus"
"594","neuromyelitis optica"
"595","neurotic disorder"
"596","osteonecrosis"
"597","osteitis deformans"
"598","panic disorder"
"599","partial epilepsy"
"600","peripheral arterial disease"
"601","primary ovarian insufficiency"
"602","biliary liver cirrhosis"
"603","sclerosing cholangitis"
"604","cardiac arrhythmia"
"605","restless legs syndrome"
"606","anemia"
"607","scoliosis"
"608","gout"
"609","Stevens-Johnson syndrome"
"610","sudden cardiac arrest"
"611","suntan"
"612","response to morphine"
"613","serum carcinoembryonic antigen measurement"
"614","lupus nephritis"
"615","neuropathic pain"
"616","pulse pressure measurement"
"617","response to haloperidol"
"618","skin fluorescence measurement"
"619","rheumatoid factor measurement"
"620","response to rate control therapy"
"621","movement disorder"
"622","testicular carcinoma"
"623","thoracic aortic aneurysm"
"624","upper aerodigestive tract neoplasm"
"625","albuminuria"
"626","venous thromboembolism"
"627","ventricular fibrillation"
"628","complement C3 measurement"
"629","complement C4 measurement"
"630","lumbar disc degeneration"
"631","total blood protein measurement"
"632","type 1 diabetes nephropathy"
"633","hippocampal volume"
"634","platelet measurement"
"635","aortic root size"
"636","hair morphology"
"637","hippocampal atrophy"
"638","survival time"
"639","insulin sensitivity measurement"
"640","CCL11 measurement"
"641","serum ceruloplasmin measurement"
"642","C-peptide measurement"
"643","respiratory quotient"
"644","urinary nitrogen measurement"
"645","waist height ratio"
"646","age at death"
"647","interleukin 10 measurement"
"648","interleukin 12 measurement"
"649","interleukin 1 receptor antagonist measurement"
"650","CCL4 measurement"
"651","parathyroid hormone measurement"
"652","myoglobin measurement"
"653","tyrosine measurement"
"654","acylcarnitine measurement"
"655","CC16 measurement"
"656","entorhinal cortical volume"
"657","hip circumference"
"658","monocyte count"
"659","P wave duration"
"660","PR segment"
"661","whole-brain volume"
"662","type 2 diabetes nephropathy"
"663","factor VIII measurement"
"664","HOMA-B"
"665","HOMA-IR"
"666","IgF-1 measurement"
"667","protein S measurement"
"668","response to clozapine"
"669","response to olanzapine"
"670","5-HIAA measurement"
"671","albumin:globulin ratio measurement"
"672","arylesterase enzyme measurement"
"673","cancer biomarker measurement"
"674","hepatitis C induced liver cirrhosis"
"675","HVA measurement"
"676","response to antimetabolite"
"677","DNA methylation"
"678","serum selenium measurement"
"679","serum copper measurement"
"680","serum zinc measurement"
"681","congenital heart malformation"
"682","sleep quality"
"683","sleep depth"
"684","sleep time"
"685","dihydroxy docosatrienoic acid measurement"
"686","Hydroxy-leucine measurement"
"687","temporomandibular joint disorder"
"688","sleep latency"
"689","word reading"
"690","anxiety"
"691","response to cisplatin"
"692","rhegmatogenous retinal detachment"
"693","employment status"
"694","methamphetamine-induced psychosis"
"695","myeloperoxidase measurement"
"696","gastric bypass"
"697","hypersomnia"
"698","anti-Heliobacter pylori serum IgG measurement"
"699","response to topoisomerase inhibitor"
"700","response to camptothecin"
"701","occupation-related stress disorder"
"702","response to cyclophosphamide"
"703","response to docetaxel"
"704","response to anthracycline-based chemotherapy"
"705","response to alcohol"
"706","ejection fraction measurement"
"707","parasitemia measurement"
"708","Chagas cardiomyopathy"
"709","urticaria"
"710","angioedema"
"711","response to non-steroidal anti-inflammatory"
"712","delayed encephalopathy after acute carbon monoxide poisoning"
"713","malignant epithelial tumor of ovary"
"714","meningioma"
"715","isolated scaphocephaly"
"716","bronchopulmonary dysplasia"
"717","thyrotoxic periodic paralysis"
"718","sickle cell anemia"
"719","granular corneal dystrophy type II"
"720","orofacial clefting syndrome"
"721","familial sick sinus syndrome"
"722","Li-Fraumeni syndrome"
"723","Moyamoya disease"
"724","response to anticoagulant"
"725","response to aromatase inhibitor"
"726","calcium measurement"
"727","CD4:CD8 lymphocyte ratio"
"728","cortical thickness"
"729","digit length ratio"
"730","eosinophil count"
"731","vitamin B measurement"
"732","hip bone size"
"733","magnesium measurement"
"734","serotonin measurement"
"735","age at onset"
"736","response to reverse transcriptase inhibitor"
"737","response to acetaminophen"
"738","response to platelet aggregation inhibitor"
"739","response to metformin"
"740","vitamin A measurement"
"741","response to ribavirin"
"742","abdominal aortic artery calcification"
"743","common carotid intimal medial thickness"
"744","phosphorus measurement"
"745","lymphoma"
"746","retinopathy"
"747","red blood cell distribution width"
"748","pulmonary hypertension"
"749","autism spectrum disorder"
"750","serum IgG glycosylation measurement"
"751","amyloid-beta measurement"
"752","antibody measurement"
"753","Epstein-Barr virus infection"
"754","cytomegalovirus infection"
"755","response to cholinesterase inhibitor"
"756","vasoactive peptide measurement"
"757","beta-2 microglobulin measurement"
"758","renal transplant outcome measurement"
"759","height growth measurement"
"760","puberty"
"761","response to hydrochlorothiazide"
"762","phytosterol measurement"
"763","recombination rate"
"764","renal sinus adipose tissue measurement"
"765","thyroid volume"
"766","autoantibody measurement"
"767","vitamin E measurement"
"768","volumetric brain MRI"
"769","YKL40 measurement"
"770","sleep measurement"
"771","memory performance"
"772","mathematical ability"
"773","acute myeloid leukemia"
"774","leukemia"
"775","prefrontal cortex cytoarchitectural measurement"
"776","influenza infection"
"777","leukopenia"
"778","serum IgG measurement"
"779","antipsychotic drug related weight gain"
"780","serum non-albumin protein measurement"
"781","aspirin induced asthma"
"782","cystic fibrosis associated meconium ileum"
"783","treatment refractory schizophrenia"
"784","factor XI measurement"
"785","intraocular pressure measurement"
"786","insomnia"
"787","response to bronchodilator"
"788","vitamin measurement"
"789","aspartate aminotransferase measurement"
"790","cytokine measurement"
"791","urinary arsenic measurement"
"792","asparaginase hypersensitivity"
"793","male infertility"
"794","meningococcal infection"
"795","myeloproliferative disorder"
"796","nasopharyngeal neoplasm"
"797","nephrolithiasis"
"798","membranous glomerulonephritis"
"799","nephrotic syndrome"
"800","blepharophimosis-ptosis-epicanthus inversus syndrome"
"801","familial hypospadias"
"802","common variable immunodeficiency"
"803","hemoglobin E disease"
"804","cystic fibrosis"
"805","Sotos syndrome"
"806","Gaucher disease"
"807","Hirschsprung disease"
"808","response to corticosteroid"
"809","aggressive behavior"
"810","cleft palate"
"811","cognition"
"812","bone quantitative ultrasound measurement"
"813","velocity of sound measurement"
"814","response to protease inhibitor"
"815","age-related hearing impairment"
"816","frontotemporal dementia"
"817","response to selective serotonin reuptake inhibitor"
"818","plasma beta-amyloid 1-40 measurement"
"819","plasma beta-amyloid 1-42 measurement"
"820","Child Behaviour Checklist assessment"
"821","blood metabolite measurement"
"822","irritable bowel syndrome"
"823","cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy"
"824","white matter hyperintensity measurement"
"825","thyroid peroxidase antibody measurement"
"826","urinary albumin excretion rate"
"827","intracerebral hemorrhage"
"828","smoking initiation"
"829","smoking behaviour measurement"
"830","familial clubfoot with or without associated lower limb anomalies"
"831","acute coronary syndrome"
"832","white matter microstructure measurement"
"833","vitamin D-binding protein measurement"
"834","autoimmune hepatits type 1"
"835","puberty onset measurement"
"836","hippocampal sclerosis of aging"
"837","conotruncal heart defect"
"838","Staphylococcus aureus infection"
"839","oxygen saturation measurement"
"840","receptive language perception"
"841","fibromyalgia"
"842","non-high density lipoprotein cholesterol measurement"
"843","musical aptitude"
"844","sarcoidosis"
"845","progressive supranuclear palsy"
"846","nephroblastoma"
"847","tuberculosis"
"848","biliary atresia"
"849","mitral annular calcification"
"850","interleukin-6 receptor measurement"
"851","alpha macroglobulin measurement"
"852","insulin like growth factor measurement"
"853","transforming growth factor beta measurement"
"854","resistin measurement"
"855","breast size"
"856","early cardiac repolarization measurement"
"857","maximal oxygen uptake measurement"
"858","post operative nausea and vomiting"
"859","postoperative ventricular dysfunction"
"860","anti-social behavior"
"861","sasang constitutional medicine"
"862","testicular dysgenesis syndrome"
"863","tetralogy of fallot"
"864","Tourette syndrome"
"865","intracranial volume measurement"
"866","pelvic organ prolapse"
"867","estradiol measurement"
"868","gambling"
"869","glycoprotein measurement"
"870","aging"
"871","sensory perception of smell"
"872","behavior"
"873","response to radiation"
"874","response to virus"
"875","response to lithium ion"
"876","response to interferon beta"
"877","response to diuretic"
"878","response to methylphenidate"
"879","response to statin"
"880","response to lapatinib"
"881","response to 5' fluorouracil"
"882","response to antidepressant"
"883","response to anticonvulsant"
"884","response to iloperidone"
"885","odontogenesis"
"886","response to drug"
"887","response to antibiotic"
"888","response to glucocorticoid"
"889","platelet aggregation"
"890","response to antineoplastic agent"
"891","response to antipsychotic drug"
"892","mean corpuscular hemoglobin concentration"
"893","internal carotid intimal medial thickness"
"894","chronic lymphocytic leukemia"
"895","neoplasm of mature b-cells"
"896","ewing sarcoma"
"897","gastric carcinoma"
"898","HIV-1 infection"
"899","hepatocellular carcinoma"
"900","hodgkins lymphoma"
"901","metabolic syndrome"
"902","plasma cell neoplasm"
"903","acute lymphoblastic leukemia"
"904","Alzheimer's disease"
"905","muscle mass measurement"
"906","amyotrophic lateral sclerosis"
"907","asthma"
"908","atopic eczema"
"909","atrial fibrillation"
"910","azoospermia"
"911","bipolar disorder"
"912","bladder carcinoma"
"913","breast carcinoma"
"914","cardiovascular disease"
"915","central nervous system cancer"
"916","chronic myelogenous leukemia"
"917","chronic obstructive pulmonary disease"
"918","colorectal cancer"
"919","keratoconus"
"920","crohn's disease"
"921","diabetes mellitus"
"922","diabetic nephropathy"
"923","diffuse large b-cell lymphoma"
"924","digestive system disease"
"925","dilated cardiomyopathy"
"926","disease free survival"
"927","emphysema"
"928","epilepsy"
"929","event free survival time"
"930","exercise"
"931","glaucoma"
"932","glioblastoma multiforme"
"933","hypertension"
"934","immune system disease"
"935","lung adenocarcinoma"
"936","myocardial infarction"
"937","narcolepsy with cataplexy"
"938","neuroblastoma"
"939","nevus"
"940","periodontitis"
"941","polycystic ovary syndrome"
"942","preeclampsia"
"943","psoriasis"
"944","mental or behavioural disorder"
"945","renal cell carcinoma"
"946","rheumatoid arthritis"
"947","schizophrenia"
"948","small cell lung carcinoma"
"949","stroke"
"950","subarachnoid hemorrhage"
"951","basophil count"
"952","systemic scleroderma"
"953","ulcerative colitis"
"954","uterine fibroid"
"955","melanoma"
"956","aids"
"957","idiopathic pulmonary fibrosis"
"958","QRS complex"
"959","comprehensive strength index"
"960","left ventricular hypertrophy"
"961","leprosy"
"962","autoimmune thyroid disease"
"963","Graves disease"
"964","Hashimoto's thyroiditis"
"965","suicide behaviour measurement"
"966","alpha peak frequency measurement"
"967","visceral:subcutaneous adipose tissue ratio"
"968","subcutaneous adipose tissue measurement"
"969","seropositivity measurement"
"970","Chlamydia pneumoniae seropositivity"
"971","herpes virus seropositivity"
"972","cytomegalovirus seropositivity"
"973","Influenza A seropositivity"
"974","human herpesvirus 8 seropositivity"
"975","blood lead measurement"
"976","obese body mass index status"
"977","polychlorinated biphenyls measurement"
"978","response to transplant"
"979","response to allogeneic hematopoietic stem cell transplant"
"980","overall survival time"
"981","response to cytokine"
"982","carotid artery intima media thickness"
"983","sitting height ratio"
"984","Sasang constitutional medicine type"
"985","Tae-Yang"
"986","So-Eum"
"987","Tae-Eum"
"988","So-Yang"
"989","blood toxic metal measurement"
"990","blood aluminium measurement"
"991","blood cadmium measurement"
"992","blood cobalt measurement"
"993","blood copper measurement"
"994","blood chromium measurement"
"995","blood mercury measurement"
"996","blood manganese measurement"
"997","blood molybdenum measurement"
"998","blood nickel measurement"
"999","blood zinc measurement"
"1000","Cannabis use"
"1001","Cannabis use initiation"
"1002","brain volume measurement"
"1003","total ventricular volume measurement"
"1004","renin–angiotensin–aldosterone system measurement"
"1005","pyoderma gangrenosum"
"1006","septic shock"
"1007","GFR change measurement"
"1008","hepatitis"
"1009","insulin metabolic clearance rate measurement"
"1010","glucose effectiveness measurement"
"1011","acute insulin response measurement"
"1012","disposition index measurement"
"1013","pneumonia"
"1014","sepsis"
"1015","myasthenia gravis"
"1016","monoclonal gammopathy"
"1017","bone mineral accretion measurement"
"1018","response to bleomycin"
"1019","chromatid break measurement"
"1020","IgG index"
"1021","motion sickness"
"1022","wet macular degeneration"
"1023","caudate nucleus volume"
"1024","nucleus accumbens volume"
"1025","putamen volume"
"1026","pallidum volume"
"1027","amygdala volume"
"1028","thalamus volume"
"1029","behavioral abnormality"
"1030","inflammatory skin disease"
"1031","recalcitrant atopic dermatitis"
"1032","colonic neoplasm"
"1033","Toxoplasma gondii seropositivity"
"1034","HSV1 seropositivity"
"1035","human herpesvirus 6 seropositivity"
"1036","gliadin seropositivity"
"1037","executive function"
"1038","vein graft stenosis"
"1039","myelosupression"
"1040","antisocial behaviour measurement"
"1041","sporadic Creutzfeld Jacobs disease"
"1042","coronary artery bypass"
"1043","cutaneous lupus erythematosus"
"1044","microsatellite instability measurement"
"1045","rectum cancer"
"1046","autoimmune pancreatitis type 1"
"1047","lachrymal gland lesion"
"1048","response to heparin"
"1049","thrombocytopenia"
"1050","perianal Crohn's disease"
"1051","ileocolitis"
"1052","erythema nodosum"
"1053","stricture"
"1054","mild disease course"
"1055","complicated disease course"
"1056","trans fatty acid measurement"
"1057","trans-16:1n-7 fatty acid measurement"
"1058","cis/trans-18:2 fatty acid measurement"
"1059","trans/trans-18:2 fatty acid measurement"
"1060","seasonality measurement"
"1061","breastfeeding duration"
"1062","cervical artery dissection"
"1063","electrodermal activity measurement"
"1064","skin conductance level"
"1065","skin conductance response amplitude"
"1066","skin conductance response frequency"
"1067","acoustic startle blink response measurement"
"1068","antisaccade response measurement"
"1069","alpha wave measurement"
"1070","beta wave measurement"
"1071","delta wave measurement"
"1072","theta wave measurement"
"1073","glucose homeostasis measurement"
"1074","airway responsiveness measurement"
"1075","airway wall thickness measurement"
"1076","PCSK9 protein measurement"
"1077","response to simvastatin"
"1078","endothelial growth factor measurement"
"1079","angiopoietin-2 measurement"
"1080","angiopoietin-2 receptor measurement"
"1081","hepatocyte growth factor measurement"
"1082","response to efavirenz"
"1083","response to abacavir"
"1084","virologic response measurement"
"1085","BNP measurement"
"1086","cardiovascular event measurement"
"1087","household air pollution measurement"
"1088","birth measurement"
"1089","delivery measurement"
"1090","fertility measurement"
"1091","lipoprotein A measurement"
"1092","marginal zone B-cell lymphoma"
"1093","response to dalcetrapib"
"1094","female fertility"
"1095","spontaneous preterm birth"
"1096","bladder exstrophy"
"1097","salivary gland neoplasm"
"1098","optic disc measurement"
"1099","optic disc area measurement"
"1100","optic rim area measurement"
"1101","cup-to-disc ratio measurement"
"1102","optic cup area measurement"
"1103","grip strength measurement"
"1104","facial pigmentation measurement"
"1105","blood pressure change measurement"
"1106","systolic blood pressure change measurement"
"1107","diastolic blood pressure change measurement"
"1108","behavioural disinhibition measurement"
"1109","red wine liking measurement"
"1110","white wine liking measurement"
"1111","response to vincristine"
"1112","ototoxicity"
"1113","cytotoxicity measurement"
"1114","developmental dysplasia of the hip"
"1115","Testicular Germ Cell Tumor"
"1116","family history of lung cancer"
"1117","response to triamcinolone acetonide"
"1118","ADAMTS13 activity measurement"
"1119","intraocular pressure change measurement"
"1120","X12063 measurement"
"1121","mannose measurement"
"1122","gene methylation measurement"
"1123","estrogen-receptor positive breast cancer"
"1124","lipoatrophy"
"1125","childhood cancer"
"1126","response to diisocyanate"
"1127","response to homoharringtonine"
"1128","response to biological dust exposure"
"1129","response to mineral dust exposure"
"1130","response to gases and fumes exposure"
"1131","response to cold medicine"
"1132","response to stavudine"
"1133","cancer aggressiveness measurement"
"1134","Gleason score measurement"
"1135","dehydroepiandrosterone sulphate measurement"
"1136","luteinizing hormone measurement"
"1137","prolactin measurement"
"1138","progesterone  measurement"
"1139","free androgen index"
"1140","depressive symptom measurement"
"1141","ticagrelor measurement"
"1142","AR-C124910XX measurement"
"1143","allergy measurement"
"1144","skin pigmentation measurement"
"1145","drug use measurement"
"1146","SSRI use measurement"
"1147","NSAID use measurement"
"1148","aspirin use measurement"
"1149","3-hydroxypropylmercapturic acid measurement"
"1150","3-hydroxy-1-methylpropylmercapturic acid measurement"
"1151","food allergy measurement"
"1152","peanut allergy measurement"
"1153","egg allergy measurement"
"1154","milk allergy measurement"
"1155","Lewy body measurement"
"1156","pituitary gland adenoma"
"1157","response to Montelukast"
"1158","response to endocrine therapy"
"1159","asthma exacerbation measurement"
"1160","thrombus formation measurement"
"1161","hearing measurement"
"1162","pure tone hearing measurement"
"1163","hearing threshold measurement"
"1164","suicide ideation measurement"
"1165","volumetric bone mineral density"
"1166","bone mineral content measurement"
"1167","sRAGE measurement"
"1168","suicide behaviour"
"1169","suicide"
"1170","longitudinal alcohol consumption measurement"
"1171","Down syndrome"
"1172","Atrioventricular canal defect"
"1173","amyloid plaque accumulation rate"
"1174","major depressive episode"
"1175","dysphagia"
"1176","gastric cardia carcinoma"
"1177","concentration dose ratio"
"1178","cutaneous melanoma"
"1179","attention function measurement"
"1180","traditional Chinese medicine type"
"1181","Yu-Zhi constitution type"
"1182","Cough"
"1183","minimal erythema dose"
"1184","response to vancomycin"
"1185","vancomycin trough measurement"
"1186","renal elimination rate measurement"
"1187","Mitral valve prolapse"
"1188","soluble interleukin-2 receptor subunit alpha measurement"
"1189","urinary S-phenylmercapturic acid measurement"
"1190","health trait"
"1191","clinical ideal cardiovascular health"
"1192","clinical and behavioural ideal cardiovascular health"
"1193","clusterin measurement"
"1194","plasma clusterin measurement"
"1195","cerebrospinal fluid clusterin measurement"
"1196","carrier status"
"1197","APOE carrier status"
"1198","cryptorchidism"
"1199","gastric adenocarcinoma"
"1200","juvenile dermatomyositis"
"1201","myositis"
"1202","polymyositis"
"1203","cancer"
"1204","autoimmune disease"
"1205","left superior temporal gyrus grey matter volume measurement"
"1206","GBA carrier status"
"1207","eye movement measurement"
"1208","exploratory eye movement measurement"
"1209","spine bone mineral density"
"1210","hip bone mineral density"
"1211","hystidil-tRNA synthetase autoantibody measurement"
"1212","depressive episode measurement"
"1213","manic episode measurement"
"1214","manic or hypomanic episode"
"1215","cardiotoxicity"
"1216","cerebral amyloid deposition measurement"
"1217","t-tau:Ab1:42 ratio"
"1218","p-tau:ab1:42 ratio"
"1219","cognitive impairment"
"1220","cognitive decline measurement"
"1221","coronary artery disease"
"1222","non-obstructive coronary artery disease"
"1223","carotid artery measurement"
"1224","carotid artery geometry measurement"
"1225","carotid artery stiffness measurement"
"1226","carotid artery external diameter measurement"
"1227","carotid artery internal diameter measurement"
"1228","carotid artery central pulse pressure measurement"
"1229","carotid artery wall cross sectional area measurement"
"1230","carotid artery mean blood pressure measurement"
"1231","carotid artery circumferential wall stress measurement"
"1232","Osteochondritis Dissecans"
"1233","extraversion"
"1234","proteinuria"
"1235","BMI-adjusted adiponectin measurement"
"1236","cingulate cortex measurement"
"1237","left superior temporal gyrus thickness measurement"
"1238","S wave amplitude"
"1239","R wave amplitude"
"1240","QRS amplitude"
"1241","primary biliary cirrhosis"
"1242","secondary biliary cirrhosis"
"1243","influenza A (H1N1)"
"1244","influenza A severity measurement"
"1245","alcoholic liver cirrhosis"
"1246","atrophic macular degeneration"
"1247","inguinal hernia"
"1248","response to beta blocker"
"1249","response to calcium channel blocker"
"1250","response to exercise"
"1251","thoracic-to-hip circumference ratio measurement"
"1252","post-operative fentanyl consumption measurement"
"1253","pathologic complete response measurement"
"1254","calcaneal bone quantitative ultrasound measurement"
"1255","abnormal thrombosis"
"1256","deep vein thrombosis"
"1257","small vessel stroke"
"1258","Cerebral arteriovenous malformation"
"1259","periodontal measurement"
"1260","primary angle closure glaucoma"
"1261","Asparaginase-induced acute pancreatitis"
"1262","mosaic loss of chromosome Y measurement"
"1263","functional decline measurement"
"1264","femoral neck bone mineral density"
"1265","BMI-adjusted waist-hip ratio"
"1266","BMI-adjusted waist circumference"
"1267","Epstein Barr virus nuclear antigen 1 IgG measurement"
"1268","rheumatoid factor seropositivity measurement"
"1269","antipsychotic drug use measurement"
"1270","low tension glaucoma"
"1271","Plasmodium falciparum antigen IgG1 measurement"
"1272","Plasmodium falciparum antigen IgG3 measurement"
"1273","Plasmodium falciparum antigen IgG measurement"
"1274","cotinine measurement"
"1275","refractive error measurement"
"1276","cannabis dependence"
"1277","fever"
"1278","response to dabrafenib"
"1279","response to trametinib"
"1280","sleep apnea measurement"
"1281","athletic endurance measurement"
"1282","advanced glycation end-product measurement"
"1283","alcohol dependence measurement"
"1284","coenzyme Q10 measurement"
"1285","response to antithyroid drug"
"1286","endometrial endometrioid carcinoma"
"1287","ovarian endometrioid carcinoma"
"1288","ovarian serous carcinoma"
"1289","head and neck malignant neoplasia"
"1290","Alagille syndrome"
"1291","Hepatic fibrosis"
"1292","seroconversion"
"1293","response to mercaptopurine"
"1294","knee peak torque measurement"
"1295","facial height measurement"
"1296","facial depth measurement"
"1297","eye morphology measurement"
"1298","gastroesophageal reflux disease"
"1299","HER2 status"
"1300","Graves ophtalmopathy"
"1301","Breslow thickness"
"1302","bacteriemia"
"1303","pneumococcal bacteremia"
"1304","pathological gambling"
"1305","cutaneous squamous cell carcinoma"
"1306","response to interferon"
"1307","ADHD symptom measurement"
"1308","reproductive behaviour measurement"
"1309","illness severity status"
"1310","sulfate measurement"
"1311","loneliness measurement"
"1312","response to rifampicin"
"1313","response to gefitinib"
"1314","response to erlotinib"
"1315","central corneal thickness"
"1316","temporal arteritis"
"1317","congestive heart failure"
"1318","lichen planus"
"1319","oral cleft"
"1320","complex regional pain syndrome"
"1321","age at voice drop"
"1322","autosomal dominant compelling helio-ophthalmic outburst syndrome"
"1323","dysmenorrheic pain measurement"
"1324","pericardial adipose tissue measurement"
"1325","skin barrier function measurement"
"1326","donor genotype effect measurement"
"1327","alpha-carotene measurement"
"1328","beta-carotene measurement"
"1329","lutein measurement"
"1330","zeaxanthin measurement"
"1331","cryptoxanthin measurement"
"1332","alpha-tocopherol measurement"
"1333","gamma-tocopherol measurement"
"1334","retinol measurement"
"1335","hepcidin:ferritin ratio"
"1336","hepcidin:transferrin saturation ratio"
"1337","magnesium:calcium ratio"
"1338","emphysema imaging measurement"
"1339","airway imaging measurement"
"1340","gas trapping measurement"
"1341","rotator cuff tear"
"1342","hemoglobin A1 measurement"
"1343","glycerophospholipid measurement"
"1344","hexose measurement"
"1345","ovarian mucinous adenocarcinoma"
"1346","Acute kidney injury"
"1347","response to thioamide"
"1348","postprandial hyperlipidemia"
"1349","neuroticism measurement"
"1350","response to triptolide"
"1351","childhood aggressive behaviour measurement"
"1352","maculopapular eruption"
"1353","response to lamotrigine"
"1354","outer ear morphology trait"
"1355","ear protrusion"
"1356","lobe size"
"1357","lobe attachment"
"1358","tragus size"
"1359","antitragus size"
"1360","helix rolling"
"1361","folding of antihelix"
"1362","crus helix expression"
"1363","superior crus of antihelix expression"
"1364","Darwin’s tubercule"
"1365","metastasis measurement"
"1366","date of diagnosis"
"1367","response to zileuton"
"1368","Ischemic stroke"
"1369","corticobasal degeneration"
"1370","noise-induced hearing loss"
"1371","LDL peak particle diameter measurement"
"1372","total fat intake measurement"
"1373","progression free survival"
"1374","oppositional defiant disorder"
"1375","metastatic colorectal cancer"
"1376","oppositional defiant disorder measurement"
"1377","gait measurement"
"1378","triglyceride change measurement"
"1379","response to cetuximab"
"1380","response to high fat food intake"
"1381","trichloroethylene-induced hypersensitivity"
"1382","altitude sickness"
"1383","coronary aneurysm"
"1384","skin and soft tissue Staphylococcus aureus infection"
"1385","late-onset myasthenia gravis"
"1386","lung disease severity measurement"
"1387","lactate measurement"
"1388","white matter lesion progression measurement"
"1389","postburn hypertrophic scarring severity measurement"
"1390","collagenous colitis"
"1391","seasonal gut microbiome composition measurement"
"1392","response to immunochemotherapy"
"1393","atopic march"
"1394","Staphylococcus aureus carrier status"
"1395","persistent Staphylococcus aureus carrier status"
"1396","alpha linolenic acid measurement"
"1397","docosahexaenoic acid measurement"
"1398","gamma linolenic acid measurement"
"1399","dihomo-gamma-linolenic acid measurement"
"1400","delta-5 desaturase measurement"
"1401","delta-6 desaturase measurement"
"1402","thrombomodulin measurement"
"1403","thrombin-antithrombin complex measurement"
"1404","prothrombin fragments F1+2 measurement"
"1405","base metabolic rate measurement"
"1406","urinary albumin to creatinine ratio"
"1407","response to pazopanib"
"1408","microalbuminuria"
"1409","glioma"
"1410","anti-citrullinated protein antibody seropositivity"
"1411","cerebral atherosclerosis"
"1412","cardiac embolism"
"1413","psoriasis vulgaris"
"1414","small artery occlusion"
"1415","cardiomyopathy"
"1416","nicotine metabolite ratio"
"1417","anxiety disorder measurement"
"1418","parental longevity"
"1419","specific language impairment"
"1420","language measurement"
"1421","linguistic error measurement"
"1422","syntactic complexity measurement"
"1423","pulmonary embolism"
"1424","body fat percentage"
"1425","lycopene measurement"
"1426","obsessive-compulsive symptom measurement"
"1427","emotional symptom measurement"
"1428","LDL cholesterol change measurement"
"1429","HDL cholesterol change measurement"
"1430","total cholesterol change measurement"
"1431","erythrocyte cadmium measurement"
"1432","response to flupirtine"
"1433","response to bortezomib"
"1434","endometrial carcinoma"
"1435","posterior cortical atrophy"
"1436","cognitive behavioural therapy"
"1437","hair morphology measurement"
"1438","hair colour measurement"
"1439","facial hair thickness measurement"
"1440","hair shape measurement"
"1441","balding measurement"
"1442","aggressive behaviour measurement"
"1443","nighttime rest measurement"
"1444","daytime rest measurement"
"1445","eating behaviour"
"1446","food addiction measurement"
"1447","clinical laboratory measurement"
"1448","metastatic prostate cancer"
"1449","squamous cell lung carcinoma"
"1450","head and neck squamous cell carcinoma"
"1451","diarrhea"
"1452","pesticide exposure measurement"
"1453","facial morphology measurement"
"1454","chin morphology measurement"
"1455","forehead morphology measurement"
"1456","lip morphology measurement"
"1457","cheekbone morphology measurement"
"1458","apolipoprotein A-IV measurement"
"1459","functional brain measurement"
"1460","solar lentigines measurement"
"1461","Bronchiolitis"
"1462","neuroendocrine neoplasm"
"1463","pulmonary neuroendocrine tumor"
"1464","pancreatic neuroendocrine tumor"
"1465","small intenstine neuroendocrine tumor"
"1466","wellbeing measurement"
"1467","late-onset Alzheimers disease"
"1468","disease recurrence"
"1469","response to clopidogrel"
"1470","Cluster headache"
"1471","response to norepinephrine-dopamine reuptake inhibitor"
"1472","response to escitalopram"
"1473","selective IgA deficiency disease"
"1474","idiopathic osteonecrosis of the femoral head"
"1475","caffeine metabolite measurement"
"1476","cartilage thickness measurement"
"1477","gut microbiome measurement"
"1478","excessive daytime sleepiness measurement"
"1479","insomnia measurement"
"1480","risky sexual behaviour measurement"
"1481","alcohol consumption measurement"
"1482","petaloid toenail"
"1483","response to dendritic cell-based immunotherapy"
"1484","oropharynx cancer"
"1485","HIV infection"
"1486","hypopharynx cancer"
"1487","pharynx cancer"
"1488","oral cavity cancer"
"1489","Sciatica"
"1490","job related exhaustion measurement"
"1491","microbiome measurement"
"1492","taxonomic microbiome measurement"
"1493","functional microbiome measurement"
"1494","cardioembolic stroke"
"1495","DDT metabolite measurement"
"1496","JT interval"
"1497","susceptibility to childhood ear infection measurement"
"1498","joint hypermobility measurement"
"1499","synophrys measurement"
"1500","AL amyloidosis"
"1501","systemic juvenile idiopathic arthritis"
"1502","methadone dose measurement"
"1503","traffic air pollution measurement"
"1504","CHGA cleavage product measurement"
"1505","CHGB cleavage product measurement"
"1506","personality trait measurement"
"1507","conscientiousness measurement"
"1508","extraversion measurement"
"1509","openness measurement"
"1510","agreeableness measurement"
"1511","response to tricyclic antidepressant"
"1512","response to tetracyclic antidepressant"
"1513","response to anti-tuberculosis drugs"
"1514","response to diclofenac"
"1515","response to fluoroquinolones"
"1516","response to nitrofurantoin"
"1517","response to sulfonylurea"
"1518","response to terbinafine"
"1519","Takotsubo cardiomyopathy"
"1520","tonsillectomy risk measurement"
"1521","radius bone mineral density"
"1522","gingival bleeding"
"1523","tiredness measurement"
"1524","serum galactose-deficient IgA1 measurement"
"1525","HIV-associated neurocognitive disorder"
"1526","acute-on-chronic liver failure"
"1527","treatment-resistant hypertension"
"1528","Varicose veins"
"1529","positive regulation of ovulation"
"1530","Hemifacial microsomia"
"1531","prolonged QT interval"
"1532","red blood cell density measurement"
"1533","childhood trauma measurement"
"1534","cerebral blood flow measurement"
"1535","response to thiazide"
"1536","mild neurocognitive disorder"
"1537","asymptomatic neurocognitive impairment"
"1538","snoring measurement"
"1539","parental emotion expression measurmement"
"1540","sex interaction measurement"
"1541","response to placebo"
"1542","response to duloxetine"
"1543","family history of upper gastrointestinal cancer"
"1544","response to trastuzumab"
"1545","response to ranibizumab"
"1546","thiazide-induced hyponatremia"
"1547","melancholia"
"1548","HPV-associated cervical carcinoma"
"1549","differentiated thyroid carcinoma"
"1550","stressful life event measurement"
"1551","endophenotype"
"1552","yang deficiency"
"1553","trans/cis-18:2 fatty acid measurement"
"1554","dementia"
"1555","total trans-18:1 fatty acid measurement"
"1556","sexual dimorphism"
"1557","thiopurine methyltransferase activity measurement"
"1558","linolenic acid measurement"
"1559","spontaneous pneumothorax"
"1560","response to CAPOX-B"
"1561","nose morphology measurement"
"1562","leukocyte immunoglobulin-like receptor subfamily B member 2 measurement"
"1563","plasma renin activity measurement"
"1564","Kunitz-type protease inhibitor 1 measurement"
"1565","rapid kidney function decline"
"1566","aggressive periodontitis"
"1567","multiple system atrophy"
"1568","intermittent Staphylococcus aureus carrier status"
"1569","facial width measurement"
"1570","Headache"
"1571","menstrual cycle measurement"
"1572","plasma betaine measurement"
"1573","hormone replacement therapy"
"1574","birth rate"
"1575","cutaneous psoriasis measurement"
"1576","eicosapentaenoic acid measurement"
"1577","estrone measurement"
"1578","gondoic acid measurement"
"1579","salivary gland lesion"
"1580","BMI-adjusted leptin measurement"
"1581","hypermetropia"
"1582","chemotherapy-induced oral mucositis"
"1583","Lewy body dementia measurement"
"1584","cerebral amyloid angiopathy"
"1585","very long-chain saturated fatty acid measurement"
"1586","estrogen-receptor negative breast cancer"
"1587","obstructive sleep apnea"
"1588","visual acuity measurement"
"1589","tumor necrosis factor receptor II measurement"
"1590","treatment outcome measurement"
"1591","TP53 mutation status"
"1592","total cortical area measurement"
"1593","perceived unattractiveness to mosquitos measurement"
"1594","P wave terminal force measurement"
"1595","mosquito bite reaction size measurement"
"1596","mosquito bite reaction itch intensity measurement"
"1597","mosquito bite measurement"
"1598","macula measurement"
"1599","liver amyloid deposition measurement"
"1600","left ventricular ejection fraction measurement"
"1601","laterality measurement"
"1602","kidney amyloid deposition measurement"
"1603","infant white matter volume measurement"
"1604","infant intracranial volume measurement"
"1605","infant grey matter volume measurement"
"1606","infant cerebrospinal fluid volume measurement"
"1607","IgG isotype profile measurement"
"1608","heart amyloid deposition measurement"
"1609","generational effect measurement"
"1610","gamma-linoleic acid measurement"
"1611","farm exposure measurement"
"1612","environmental tobacco smoke exposure measurement"
"1613","environmental exposure measurement"
"1614","eicosadienoic acid measurement"
"1615","dorsolateral prefrontal cortex functional measurement"
"1616","docosatetranoic acid measurement"
"1617","dihomo-gamma-linoleic acid measurement"
"1618","dietary heme iron intake measurement"
"1619","cognitive function measurement"
"1620","cellular adhesion molecule measurement"
"1621","C9orf72 mutation status"
"1622","amyloid deposition measurement"
"1623","alpha-linoleic acid measurement"
"1624","infectious mononucleosis"
"1625","chickenpox"
"1626","scarlet fever"
"1627","hepatitis A"
"1628","urinary tract infection"
"1629","rheumatic fever"
"1630","common cold"
"1631","limited scleroderma"
"1632","diffuse scleroderma"
"1633","oligoarticular juvenile idiopathic arthritis"
"1634","polyarticular juvenile idiopathic arthritis, rheumatoid factor negative"
"1635","nonalcoholic steatohepatitis"
"1636","spinal stenosis"
"1637","ankle injury"
"1638","body odour measurement"
"1639","caudate nucleus measurement"
"1640","gamma wave measurement"
"1641","putamen measurement"
"1642","prothrombin time measurement"
"1643","erythropoetin measurement"
"1644","triiodothyronine measurement"
"1645","reaction time measurement"
"1646","verbal-numerical reasoning measurement"
"1647","response to darapladib"
"1648","response to reward"
"1649","response to disappointment"
"1650","appendicular lean mass"
"1651","T wave morphology measurement"
"1652","mean fractional anisotropy measurement"
"1653","susceptibility to chickenpox measurement"
"1654","susceptibility to shingles measurement"
"1655","susceptibility to cold sores measurement"
"1656","susceptibility to mononucleosis measurement"
"1657","susceptibility to mumps measurement"
"1658","susceptibility to hepatitis B infection measurement"
"1659","susceptibility to plantar warts measurement"
"1660","susceptibility to Mycobacterium tuberculosis infection measurement"
"1661","susceptibility to strep throat measurement"
"1662","susceptibility to scarlet fever measurement"
"1663","susceptibility to pneumonia measurement"
"1664","susceptibility to bacterial meningitis measurement"
"1665","susceptibility to vaginal yeast infection measurement"
"1666","susceptibility to urinary tract infection measurement"
"1667","digestive system carcinoma"
"1668","agoraphobia symptom measurement"
"1669","Young adult-onset Parkinsonism"
"1670","bone fracture"
"1671","[Pyruvate dehydrogenase acetyl-transferring] kinase isozyme 1, mitochondrial measurement"
"1672","1,5 anhydroglucitol measurement"
"1673","a disintegrin and metalloproteinase with thrombospondin motifs 13"
"1674","Abelson tyrosine-protein kinase 2 measurement"
"1675","acid sphingomyelinase-like phosphodiesterase 3a measurement"
"1676","ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 measurement"
"1677","afamin measurement"
"1678","age at assessment"
"1679","Agouti-related protein measurement"
"1680","alcohol dehydrogenase [NADP+] measurement"
"1681","alcoholic pancreatitis"
"1682","alpha-1-antichymotrypsin complex measurement"
"1683","alpha-1-antichymotrypsin measurement"
"1684","alpha-2-HS-glycoprotein measurement"
"1685","alpha-2-macroglobulin receptor-associated protein measurement"
"1686","angiogenin measurement"
"1687","angiopoietin-1 receptor, soluble measurement"
"1688","angiostatin measurement"
"1689","angiotensinogen measurement"
"1690","annexin A1 measurement"
"1691","annexin A2 measurement"
"1692","apolipoprotein E isoform E2 measurement"
"1693","apolipoprotein E measurement"
"1694","arylsulfatase B measurement"
"1695","aspartate aminotransferase, cytoplasmic measurement"
"1696","basal cell adhesion molecule measurement"
"1697","benign prostatic hyperplasia"
"1698","beta-Ala-His dipeptidase measurement"
"1699","beta-endorphin measurement"
"1700","beta-nerve growth factor measurement"
"1701","BMI-adjusted fasting blood glucose measurement"
"1702","BMI-adjusted fasting blood insulin measurement"
"1703","BMI-adjusted hip bone size"
"1704","BMI-adjusted hip circumference"
"1705","borderline personality disorder"
"1706","breast cancer anti-estrogen resistance protein 3 measurement"
"1707","C-C motif chemokine 1 measurement"
"1708","C-C motif chemokine 14 measurement"
"1709","C-C motif chemokine 15 measurement"
"1710","C-C motif chemokine 16 measurement"
"1711","C-C motif chemokine 17 measurement"
"1712","C-C motif chemokine 18 measurement"
"1713","C-C motif chemokine 19 measurement"
"1714","C-C motif chemokine 21 measurement"
"1715","C-C motif chemokine 23 measurement"
"1716","C-C motif chemokine 25 measurement"
"1717","C-C motif chemokine 3 measurement"
"1718","C-C motif chemokine 5 measurement"
"1719","C-C motif chemokine 7 measurement"
"1720","C-C motif chemokine 8 measurement"
"1721","C-X-C motif chemokine 10 measurement"
"1722","C-X-C motif chemokine 11 measurement"
"1723","C-X-C motif chemokine 5 measurement"
"1724","C-X-C motif chemokine 6 measurement"
"1725","cadherin-5 measurement"
"1726","calcineurin measurement"
"1727","calcium/calmodulin-dependent protein kinase type 1 measurement"
"1728","calcium/calmodulin-dependent protein kinase type 1D measurement"
"1729","calpain I measurement"
"1730","calpastatin measurement"
"1731","carbohydrate sulfotransferase 15 measurement"
"1732","carbonic anhydrase 13 measurement"
"1733","carbonic anhydrase 6 measurement"
"1734","carboxypeptidase B2 measurement"
"1735","caspase-3 measurement"
"1736","cathepsin B measurement"
"1737","cathepsin S measurement"
"1738","cathepsin Z measurement"
"1739","cation-independent mannose-6-phosphate receptor measurement"
"1740","CD109 antigen measurement"
"1741","CD27 antigen measurement"
"1742","cell adhesion molecule-related/down-regulated by oncogenes measurement"
"1743","cerebrospinal fluid volume measurement"
"1744","cGMP-specific 3’,5’-cyclic phosphodiesterase measurement"
"1745","chemokine (C-C motif) ligand 27 measurement"
"1746","chemokine (C-X-C motif) ligand 1 measurement"
"1747","chitotriosidase-1 measurement"
"1748","Ck-beta-8-1 measurement"
"1749","CMRF35-like molecule 6 measurement"
"1750","coagulation factor V measurement"
"1751","collectin-11 measurement"
"1752","complement C1q subcomponent measurement"
"1753","complement C1r subcomponent measurement"
"1754","complement C1s subcomponent measurement"
"1755","complement C4b measurement"
"1756","complement component C7 measurement"
"1757","complement component C8 measurement"
"1758","complement decay-accelerating factor measurement"
"1759","complement factor B measurement"
"1760","complement factor H measurement"
"1761","complement factor H-related protein 5 measurement"
"1762","complement factor I measurement"
"1763","contactin-2 measurement"
"1764","contactin-5 measurement"
"1765","copine-1 measurement"
"1766","cystatin-D measurement"
"1767","cystatin-F measurement"
"1768","cystatin-SA measurement"
"1769","cystatin-SN measurement"
"1770","death-associated protein kinase 2 measurement"
"1771","dermatopontin measurement"
"1772","Dickkopf-related protein 3 measurement"
"1773","Dickkopf-related protein 4 measurement"
"1774","diet measurement"
"1775","dual specificity mitogen-activated protein kinase kinase 2 measurement"
"1776","dual specificity mitogen-activated protein kinase kinase 4 measurement"
"1777","dynein light chain roadblock-type 1 measurement"
"1778","ectonucleoside triphosphate diphosphohydrolase 5 measurement"
"1779","EGF-like module-containing mucin-like hormone receptor-like 2 measurement"
"1780","elafin measurement"
"1781","endoglin measurement"
"1782","endoplasmic reticulum aminopeptidase 1 measurement"
"1783","endothelial cell-selective adhesion molecule measurement"
"1784","endothelin-converting enzyme 1 measurement"
"1785","eotaxin measurement"
"1786","ephrin type-A receptor 1 measurement"
"1787","ephrin type-B receptor 2 measurement"
"1788","estrogen receptor measurement"
"1789","extracellular matrix protein 1 measurement"
"1790","Fc receptor-like protein 3 measurement"
"1791","fetuin-B measurement"
"1792","fibroblast growth factor 2 measurement"
"1793","fibroblast growth factor basic measurement"
"1794","fibronectin fragment 3 measurement"
"1795","fibronectin fragment 4 measurement"
"1796","fibronectin measurement"
"1797","ficolin-1 measurement"
"1798","ficolin-2 measurement"
"1799","galactoside 34-L-fucosyltransferase measurement"
"1800","galectin-3 measurement"
"1801","GDNF family receptor alpha-2 measurement"
"1802","glypican-5 measurement"
"1803","gp41 C34 peptide, HIV measurement"
"1804","granulins measurement"
"1805","granulocyte colony-stimulating factor measurement"
"1806","granulysin measurement"
"1807","granzyme A measurement"
"1808","growth-regulated alpha protein measurement"
"1809","gwas_trait"
"1810","hemojuvelin measurement"
"1811","hemopexin measurement"
"1812","heparin cofactor 2 measurement"
"1813","hepatitis A virus cellular receptor 2 measurement"
"1814","hepatocyte growth factor activator measurement"
"1815","hepatocyte growth factor receptor measurement"
"1816","hepatocyte growth factor-like protein measurement"
"1817","histidine-rich glycoprotein measurement"
"1818","human Chorionic Gonadotropin measurement"
"1819","inorganic pyrophosphatase measurement"
"1820","inosine-5-monophosphate dehydrogenase 1 measurement"
"1821","inosine-5-monophosphate dehydrogenase 2 measurement"
"1822","insulin receptor measurement"
"1823","insulin-like growth factor-binding protein 7 measurement"
"1824","integrin alpha-I: beta-1 complex measurement"
"1825","intercellular adhesion molecule 2 measurement"
"1826","intercellular adhesion molecule 5 measurement"
"1827","interferon gamma measurement"
"1828","interleukin 1 Receptor accessory protein measurement"
"1829","interleukin 1 receptor-like 1 measurement"
"1830","interleukin 1 receptor-like 2 measurement"
"1831","interleukin 12 receptor subunit beta-1 measurement"
"1832","interleukin 13 measurement"
"1833","creatinine clearance measurement"
"1834","urinary uric acid to creatinine ratio"
"1835","disease prognosis measurement"
"1836","high-altitude pulmonary edema"
"1837","rheumatic heart disease"
"1838","mouth morphology measurement"
"1839","monocyte:lymphocyte ratio"
"1840","macular telangiectasia type 2"
"1841","fetal genotype effect measurement"
"1842","organochlorine pesticide measurement"
"1843","polybrominated biphenyl measurement"
"1844","polybrominated diphenyl ether measurement"
"1845","abnormal paneth cell measurement"
"1846","gestational serum measurement"
"1847","response to combination chemotherapy"
"1848","Tendinopathy"
"1849","ligament rupture"
"1850","clopidogrel metabolite measurement"
"1851","blood osmolality measurement"
"1852","tissue factor pathway inhibitor measurement"
"1853","cognitive inhibition measurement"
"1854","estrone conjugate measurement"
"1855","androstenedione measurement"
"1856","palmitoleic acid measurement"
"1857","vaccenic acid measurement"
"1858","erucic acid measurement"
"1859","nervonic acid measurement"
"1860","cognitive impairment measurement"
"1861","diabetic foot"
"1862","lower body strength measurement"
"1863","peak insulin response measurement"
"1864","insulin secretion rate measurement"
"1865","physical activity measurement"
"1866","heart rate variability measurement"
"1867","resting metabolic rate measurement"
"1868","energy expenditure measurement"
"1869","skin aging measurement"
"1870","interleukin 15 receptor subunit alpha measurement"
"1871","interleukin 16 measurement"
"1872","interleukin 17 measurement"
"1873","interleukin 17 receptor A measurement"
"1874","interleukin 17 receptor B measurement"
"1875","interleukin 17 receptor D measurement"
"1876","interleukin 18 receptor 1 measurement"
"1877","interleukin 18 receptor accessory protein measurement"
"1878","interleukin 19 measurement"
"1879","interleukin 23 receptor measurement"
"1880","interleukin 25 measurement"
"1881","interleukin 27 receptor subunit alpha measurement"
"1882","interleukin 4 measurement"
"1883","interleukin 5 measurement"
"1884","interleukin 5 receptor subunit alpha measurement"
"1885","interleukin 6 receptor subunit alpha measurement"
"1886","interleukin 6 receptor subunit beta measurement"
"1887","interleukin 7 measurement"
"1888","interleukin 7 receptor subunit alpha measurement"
"1889","interleukin 8 measurement"
"1890","interleukin 9 measurement"
"1891","interstitial collagenase measurement"
"1892","kallikrein-12 measurement"
"1893","kallikrein-7 measurement"
"1894","kallistatin measurement"
"1895","killer cell immunoglobulin-like receptor 2DL4 measurement"
"1896","kininogen-1 measurement"
"1897","Kunitz-type protease inhibitor 2 measurement"
"1898","kynureninase measurement"
"1899","L-Selectin measurement"
"1900","lactadherin measurement"
"1901","left ventricular diastolic function measurement"
"1902","left ventricular structural measurement"
"1903","left ventricular systolic function measurement"
"1904","leucine carboxyl methyltransferase 1 measurement"
"1905","leukocyte immunoglobulin-like receptor subfamily B member 1 measurement"
"1906","low affinity immunoglobulin epsilon Fc receptor measurement"
"1907","low affinity immunoglobulin gamma Fc region receptor II-a/b measurement"
"1908","low affinity immunoglobulin gamma Fc region receptor III-B measurement"
"1909","low molecular weight phosphotyrosine protein phosphatase measurement"
"1910","lower urinary tract symptom"
"1911","lymphotactin measurement"
"1912","lysosomal protective protein measurement"
"1913","lysozyme C measurement"
"1914","macrophage colony stimulating factor measurement"
"1915","macrophage inflammatory protein 1a measurement"
"1916","macrophage inflammatory protein 1b measurement"
"1917","macrophage metalloelastase measurement"
"1918","macrophage migration inhibitory factor measurement"
"1919","macrophage scavenger receptor types I and II measurement"
"1920","mannan-binding lectin serine protease 1 measurement"
"1921","mannose-binding protein C measurement"
"1922","MAP kinase-activated protein kinase 2 measurement"
"1923","MAP kinase-activated protein kinase 3 measurement"
"1924","matrilysin measurement"
"1925","mediator of RNA polymerase II transcription subunit 1 measurement"
"1926","melanoma-derived growth regulatory protein measurement"
"1927","mental development measurement"
"1928","metalloproteinase inhibitor 3 measurement"
"1929","methionine aminopeptidase 2 measurement"
"1930","MHC class I polypeptide-related sequence A measurement"
"1931","MHC class I polypeptide-related sequence B measurement"
"1932","monocyte chemotactic protein 3 measurement"
"1933","monokine induced by gamma interferon measurement"
"1934","motor development measurement"
"1935","myeloid cell surface antigen CD33 measurement"
"1936","N-acetyl-D-glucosamine kinase measurement"
"1937","N-acylethanolamine-hydrolyzing acid amidase measurement"
"1938","NAD-dependent protein deacetylase sirtuin-2 measurement"
"1939","NADPH--cytochrome P450 reductase measurement"
"1940","natural cytotoxicity triggering receptor 3 measurement"
"1941","neurexophilin-1 measurement"
"1942","neurodevelopmental measurement"
"1943","neurogenic locus notch homolog protein 1 measurement"
"1944","neutral ceramidase measurement"
"1945","neutrophil collagenase measurement"
"1946","nidogen-1 measurement"
"1947","NKG2-D type II integral membrane protein measurement"
"1948","non-receptor tyrosine-protein kinase TYK2 measurement"
"1949","OCIA domain-containing protein 1 measurement"
"1950","OX-2 membrane glycoprotein measurement"
"1951","P-Selectin measurement"
"1952","particulate matter air pollution measurement"
"1953","peptidyl-prolyl cis-trans isomerase D measurement"
"1954","peptidyl-prolyl cis-trans isomerase E measurement"
"1955","persulfide dioxygenase ETHE1, mitochondrial measurement"
"1956","phospholipase A2, membrane associated measurement"
"1957","plasma kallikrein measurement"
"1958","plasma protease C1 inhibitor measurement"
"1959","platelet glycoprotein 4 measurement"
"1960","platelet glycoprotein VI measurement"
"1961","platelet-derived growth factor BB measurement"
"1962","platelet-derived growth factor receptor beta measurement"
"1963","plexin-C1 measurement"
"1964","polymeric immunoglobulin receptor measurement"
"1965","programmed cell death 1 ligand 2 measurement"
"1966","properdin measurement"
"1967","proprotein convertase subtilisin/kexin type 7 measurement"
"1968","protein jagged-1 measurement"
"1969","proto-oncogene tyrosine-protein kinase receptor Ret measurement"
"1970","repulsive guidance molecule A measurement"
"1971","retinoic acid receptor responder protein 2 measurement"
"1972","S-formylglutathione hydrolase measurement"
"1973","scavenger receptor class F member 1 measurement"
"1974","Secreted frizzled-related protein 3 measurement"
"1975","semaphorin-3A measurement"
"1976","semaphorin-3E measurement"
"1977","serine protease 27 measurement"
"1978","serine/threonine-protein kinase 17B measurement"
"1979","serum amyloid A-1 protein measurement"
"1980","serum amyloid P-component measurement"
"1981","sialic acid-binding Ig-like lectin 14 measurement"
"1982","sialic acid-binding Ig-like lectin 6 measurement"
"1983","sialic acid-binding Ig-like lectin 9 measurement"
"1984","SLAM family member 7 measurement"
"1985","small nuclear ribonucleoprotein F measurement"
"1986","SPARC-like protein 1 measurement"
"1987","spondin-1 measurement"
"1988","stem Cell Factor measurement"
"1989","stem Cell Growth Factor beta measurement"
"1990","stromal cell-derived factor 1 alpha measurement"
"1991","superoxide dismutase [Mn], mitochondrial measurement"
"1992","T-lymphocyte surface antigen Ly-9 measurement"
"1993","tenascin measurement"
"1994","teratocarcinoma-derived growth factor 1 measurement"
"1995","thioredoxin domain-containing protein 12 measurement"
"1996","response to paliperidone"
"1997","core binding factor acute myeloid leukemia"
"1998","hyper-inflammatory immune response"
"1999","schizophrenia symptom severity measurement"
"2000","ventricular rate measurement"
"2001","triglyceride:HDL cholesterol ratio"
"2002","LDL cholesterol:HDL cholesterol ratio"
"2003","non-HDL cholesterol:HDL cholesterol ratio"
"2004","mulitple keratinocyte carcinoma susceptibility measurement"
"2005","generalized anxiety disorder"
"2006","ovarian clear cell adenocarcinoma"
"2007","blood protein measurement"
"2008","coronary atherosclerosis measurement"
"2009","respiratory symptom measurement"
"2010","chronic venous insufficiency"
"2011","LDH-related sciatica symptom severity measurement"
"2012","hip osteoarthritis symptom severity measurement"
"2013","hypersensitivity reaction disease"
"2014","drug hypersensitivity syndrome"
"2015","lumbar disc herniation"
"2016","response to platinum-based neoadjuvant chemotherapy"
"2017","Neonatal sepsis"
"2018","antiphospholipid syndrome"
"2019","premature birth"
"2020","urinary 1,3-butadiene measurement"
"2021","TP53 positive breast cancer"
"2022","adult onset asthma"
"2023","platelet distribution width"
"2024","plateletcrit"
"2025","reticulocyte count"
"2026","granulocyte count"
"2027","myeloid white cell count"
"2028","monocyte percentage of white cells"
"2029","neutrophil percentage of white cells"
"2030","eosinophil percentage of white cells"
"2031","basophil percentage of white cells"
"2032","lymphocyte percentage of white cells"
"2033","neutrophil percentage of granulocytes"
"2034","basophil percentage of granulocytes"
"2035","eosinophil percentage of granulocytes"
"2036","granulocyte percentage of myeloid white cells"
"2037","uveal melanoma"
"2038","thrombospondin-2 measurement"
"2039","TNF-related apoptosis-inducing ligand measurement"
"2040","toll-like receptor 4:Lymphocyte antigen 96 complex measurement"
"2041","transforming growth factor-beta-induced protein ig-h3 measurement"
"2042","transmembrane glycoprotein NMB measurement"
"2043","trefoil factor 3 measurement"
"2044","trypsin-2 measurement"
"2045","tryptase beta-2 measurement"
"2046","tuberculin skin test reactivity measurement"
"2047","tumor necrosis factor beta measurement"
"2048","tumor necrosis factor receptor superfamily member 19L measurement"
"2049","tumor necrosis factor receptor superfamily member EDAR measurement"
"2050","tumor necrosis factor-inducible gene 6 protein measurement"
"2051","tyrosine-protein kinase receptor Tie-1, soluble measurement"
"2052","UMP-CMP kinase measurement"
"2053","vascular endothelial growth factor receptor 2 measurement"
"2054","vascular endothelial growth factor receptor 3 measurement"
"2055","vaso-occlusive pain measurement"
"2056","very low density lipoprotein cholesterol measurement"
"2057","vitamin K-dependent protein C measurement"
"2058","WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 measurement"
"2059","white matter volume measurement"
"2060","WNT1-inducible-signaling pathway protein 1 measurement"
"2061","a disintegrin and metalloproteinase with thrombospondin motifs 5 measurement"
"2062","alpha-1-antitrypsin measurement"
"2063","chronotype measurement"
"2064","facial emotion recognition measurement"
"2065","fear of pain measurement"
"2066","interleukin 2 measurement"
"2067","interleukin 2 receptor antagonist measurement"
"2068","T wave amplitude"
"2069","TpTe measurement"
"2070","ventricular repolarisation duration measurement"
"2071","cervical squamous cell carcinoma"
"2072","decreased susceptibility to bacterial infection"
"2073","hypocretin deficiency"
"2074","response to sulfasalazine"
"2075","response to sotalol"
"2076","Huntington disease"
"2077","disease progression measurement"
"2078","psychosis predisposition measurement"
"2079","fear of severe pain measurement"
"2080","fear of medical pain measurement"
"2081","fear of minor pain measurement"
"2082","apolipoprotein B measurement"
"2083","Henoch-Schoenlein purpura"
"2084","angina pectoris"
"2085","percutaneous transluminal coronary angioplasty"
"2086","ischemic cardiomyopathy"
"2087","follicular thyroid carcinoma"
"2088","papillary thyroid carcinoma"
"2089","infant"
"2090","Hepatitis, Alcoholic"
"2091","age at menarche"
"2092","podoconiosis"
"2093","pemphigus vulgaris"
"2094","serum amyloid a protein measurement"
"2095","renal system measurement"
"2096","thyroid stimulating hormone measurement"
"2097","genetic variation"
"2098","response to gemcitabine"
"2099","callous character"
"2100","adhesion molecule measurement"
"2101","amygdala reactivity measurement"
"2102","CYP3A4 activity"
"2103","phenylalanine measurement"
"2104","QRS duration"
"2105","antiphospholipid antibody measurement"
"2106","eating disorder"
"2107","congenital heart disease"
"2108","aortic valve calcification"
"2109","body weight loss"
"2110","malignant pleural mesothelioma"
"2111","osteosarcoma"
"2112","sleep duration"
"2113","cardiovascular disease biomarker measurement"
"2114","migraine without aura"
"2115","reading and spelling ability"
"2116","Brugada syndrome"
"2117","Sjogren syndrome"
"2118","liver disease"
"2119","chemotherapy-induced alopecia"
"2120","colorectal adenoma"
"2121","functional impairment measurement"
"2122","serum dimethylarginine measurement"
"2123","autism spectrum disorder symptom"
"2124","large artery stroke"
"2125","Trypanosoma cruzi seropositivity"
"2126","limb dystonia"
"2127","serum metabolite measurement"
"2128","response to cytosine arabinoside"
"2129","urinary uromodulin measurement"
"2130","anterior chamber depth measurement"
"2131","chronic mucus hypersecretion"
"2132","omega-6 polyunsaturated fatty acid measurement"
"2133","plasma trimethylamine N-oxide measurement"
"2134","age-related nuclear cataract"
"2135","Birdshot chorioretinopathy"
"2136","opioid dependence"
"2137","C-C motif chemokine 3-like 1 measurement"
"2138","CD209 antigen measurement"
"2139","catalase measurement"
"2140","allergen exposure measurement"
"2141","urgency urinary incontinence"
"2142","pit and fissure surface dental caries"
"2143","metabolic network measurement"
"2144","Hodgkin's lymphoma, mixed cellularity"
"2145","behavioural inhibitory control measurement"
"2146","midregional pro atrial natriuretic peptide measurement"
"2147","B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio"
"2148","dietary potassium intake measurement"
"2149","insulin response measurement"
"2150","spine bone mineral density change measurement"
"2151","mood instability measurement"
"2152","delayed reward discounting measurement"
"2153","response to trauma exposure"
"2154","homosexuality"
"2155","male homosexuality"
"2156","epigenetic status"
"2157","helping behavior measurement"
"2158","sperm motility measurement"
"2159","corneal astigmatism"
"2160","response to taxane"
"2161","thrombin activatable fibrinolysis inhibitor activation peptide measurement"
"2162","risk-taking behaviour"
"2163","Plantar Fasciitis"
"2164","Plantar Fibromatosis"
"2165","hyperuricemia"
"2166","non-typhoidal Salmonella bacteremia"
"2167","high altitude adaptation"
"2168","clostridium difficile infection"
"2169","response to polyunsaturated fatty acid supplementation"
"2170","cholesterol efflux capacity measurement"
"2171","cholesteryl ester transfer protein measurement"
"2172","trimethyllysine measurement"
"2173","heart rate response to exercise"
"2174","heart rate response to recovery post exercise"
"2175","Abruptio Placentae"
"2176","interventricular septum thickness"
"2177","E/A ratio"
"2178","neurobehavioral manifestations"
"2179","memory impairment"
"2180","Alopecia"
"2181","skin disease"
"2182","susceptibility to infectious disease measurement"
"2183","nicotine withdrawal measurement"
"2184","energy intake measurement"
"2185","alcohol use disorder measurement"
"2186","ACPA-negative rheumatoid arthritis"
"2187","ACPA-positive rheumatoid arthritis"
"2188","bacterial endocarditis"
"2189","Löfgren’s syndrome"
"2190","response to anti-vascular endothelial growth factor drug"
"2191","coping behaviour measurement"
"2192","Guillain-Barre syndrome"
"2193","hyperthyroidism"
"2194","AQP4-IgG-positive neuromyelitis optica"
"2195","AQP4-IgG-negative neuromyelitis optica"
"2196","skin hydration measurement"
"2197","anhedonia measurement"
"2198","social interaction measurement"
"2199","worry measurement"
"2200","irritability measurment"
"2201","feeling miserable measurement"
"2202","mood change measurement"
"2203","feeling ""fed-up"" measurement"
"2204","feeling nervous measurement"
"2205","feeling tense measurement"
"2206","feeling emotionally hurt measurement"
"2207","guilt measurement"
"2208","verbal memory measurement"
"2209","visual memory measurement"
"2210","stroke outcome severity measurement"
"2211","Marfan syndrome"
"2212","amebiasis"
"2213","Charcot-Marie-Tooth disease type 1A"
"2214","thiopurine metabolite measurement"
"2215","fractures, ununited"
"2216","red blood cell folate measurement"
"2217","epilepsy with generalized tonic-clonic seizures"
"2218","intra-individual reaction time variability measurement"
"2219","latent autoimmune diabetes in adults"
"2220","HER2 positive breast carcinoma"
"2221","dissociation measurement"
"2222","response to ketamine"
"2223","age at first sexual intercourse measurement"
"2224","facial asymmetry measurement"
"2225","visuospatial impairment"
"2226","Chronic Obstructive Asthma"
"2227","Juvenile myoclonic epilepsy"
"2228","Juvenile absence epilepsy"
"2229","Childhood absence epilepsy"
"2230","anti-Mullerian hormone measurement"
"2231","estrogen receptor status"
"2232","periprosthetic osteolysis"
"2233","place of residence measurement"
"2234","vascular disease"
"2235","body weights and measures"
"2236","Abnormality of lipid metabolism"
"2237","asparaginase activity measurement"
"2238","fatty acid desaturase enzyme activity measurement"
"2239","valine measurement"
"2240","isoleucine measurement"
"2241","NRF2 measurement"
"2242","serum urea measurement"
"2243","response to supplemental oxygen"
"2244","lung disease associated with cystic fibrosis"
"2245","Modic type vertebral endplate changes"
"2246","appendicitis"
"2247","transcriptome measurement"
"2248","nonischemic cardiomyopathy"
"2249","anxiety measurement"
"2250","urinary potassium to creatinine ratio"
"2251","urinary sodium to creatinine ratio"
"2252","urinary sodium to potassium ratio"
"2253","frailty measurement"
"2254","tinnitus"
"2255","narcolepsy"
"2256","urolithiasis"
"2257","carbamazepine metabolite measurement"
"2258","lean mass-adjusted fat body mass"
"2259","anti-thyroglobulin antibody measurement"
"2260","oral ulcer"
"2261","handedness"
"2262","central nervous system non-hodgkin lymphoma"
"2263","colonic diverticula"
"2264","Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement"
"2265","Drugs used in diabetes use measurement"
"2266","Antithrombotic agent use measurement"
"2267","Vasodilators used in cardiac diseases use measurement"
"2268","Antihypertensive use measurement"
"2269","Diuretic use measurement"
"2270","Beta blocking agent use measurement"
"2271","Calcium channel blocker use measurement"
"2272","Agents acting on the renin-angiotensin system use measurement"
"2273","HMG CoA reductase inhibitor use measurement"
"2274","Thyroid preparation use measurement"
"2275","Immunosuppressant use measurement"
"2276","Non-steroidal anti-inflammatory and antirheumatic product use measurement"
"2277","Drugs affecting bone structure and mineralization use measurement"
"2278","Opioid use measurement"
"2279","Anilide use measurement"
"2280","Antimigraine preparation use measurement"
"2281","Antidepressant use measurement"
"2282","Inhalant adrenergic use measurement"
"2283","Glucocorticoid use measurement"
"2284","Antihistamine use measurement"
"2285","Antiglaucoma preparations and miotics use measurement"
"2286","psychological resilience measurement"
"2287","low density lipoprotein triglyceride measurement"
"2288","nucleoside diphosphate kinase A measurement"
"2289","chorioamnionitis"
"2290","KANNO antigen measurement"
"2291","post-operative atrial fibrillation"
"2292","post-operative myocardial infarction"
"2293","post-operative delirium"
"2294","post-operative acute kidney injury"
"2295","post-operative stroke"
"2296","response to surgery"
"2297","post-operative sign or symptom"
"2298","Reduced ejection fraction"
"2299","pemphigus"
"2300","response to bisphosphonate"
"2301","atypical femoral fracture"
"2302","susceptibility to measles measurement"
"2303","susceptibility to hepatitis A infection measurement"
"2304","susceptibility to rheumatic fever measurement"
"2305","susceptibility to common cold measurement"
"2306","susceptibility to rubella infection measurement"
"2307","susceptibility to chronic sinus infection measurement"
"2308","parietal cortex measurement"
"2309","non-alcoholic fatty liver disease severity measurement"
"2310","IgG monogalactosylation measurement"
"2311","IgG digalactosylation measurement"
"2312","IgG galactosylation measurement"
"2313","IgG bisecting N-acetyl glucosamine measurement"
"2314","IgG fucosylation measurement"
"2315","IgG sialylation measurement"
"2316","IgG disialylation measurement"
"2317","IgG monosialylation measurement"
"2318","maximal voluntary ventilation"
"2319","lipoprotein-associated phospholipase A(2) change measurement"
"2320","pursuit maintenance gain measurement"
"2321","initial pursuit acceleration"
"2322","gestational weight gain measurement"
"2323","late gestational weight gain"
"2324","early gestational weight gain"
"2325","growth hormone measurement"
"2326","chronic rhinosinusitis"
"2327","response to carbamazepine"
"2328","chronic rhinosinusitis with nasal polyps"
"2329","chronic rhinosinusitis without nasal polyps"
"2330","meningeal tuberculosis"
"2331","kynurenine measurement"
"2332","kynurenine:tryptophan ratio"
"2333","GLP-1-stimulated insulin response"
"2334","clinically amyopathic dermatomyositis"
"2335","vitamin D dietary intake measurement"
"2336","response to opioid"
"2337","complement C3d subcomponent measurement"
"2338","c3d:C3 ratio"
"2339","analgesia requirement measurement"
"2340","autoimmune hepatitis"
"2341","HSV2 virologic severity measurement"
"2342","aortic stenosis"
"2343","breast milk measurement"
"2344","choroidal melanoma"
"2345","idiopathic dilated cardiomyopathy"
"2346","tobacco smoke exposure measurement"
"2347","vitamin supplement exposure measurement"
"2348","alcohol exposure measurement"
"2349","in utero exposure measurement"
"2350","aortic coarctation"
"2351","idiopathic intracranial hypertension"
"2352","necrotizing enterocolitis"
"2353","delirium"
"2354","standard deviation of the normal-to-normal inter beat intervals"
"2355","root mean square of the successive differences of inter beat intervals"
"2356","peak-valley respiratory sinus arrhythmia or high frequency power"
"2357","non-melanoma skin carcinoma"
"2358","Hyperhidrosis"
"2359","proprotein convertase subtilisin/kexin type 9 measurementhyperhidrosis"
"2360","Sickle cell disease and related diseases"
"2361","colorectal mucinous adenocarcinoma"
"2362","vestibular neuronitis"
"2363","fibroblast growth factor 23 measurement"
"2364","metabolically healthy obesity"
"2365","pemphigus foliaceus"
"2366","Takayasu arteritis"
"2367","sum of neutrophil and eosinophil counts"
"2368","response to tamoxifen"
"2369","glucose metabolism decline measurement"
"2370","breast pressure measurement"
"2371","hippocampal CA1 volume"
"2372","hippocampal CA3 volume"
"2373","hippocampal CA4 volume"
"2374","hippocampus molecular layer volume"
"2375","hippocampal tail volume"
"2376","subiculum volume"
"2377","presubiculum volume"
"2378","hippocampal amigdala transition area volume"
"2379","hippocampus fimbria volume"
"2380","arthralgia"
"2381","B-cell non-Hodgkins lymphoma"
"2382","facial wrinkling"
"2383","Stiff neck"
"2384","metrorrhagia"
"2385","abnormal vaginal discharge smell"
"2386","abnormal vaginal discharge itching"
"2387","abnormal peristalsis"
"2388","nervousness"
"2389","sleepiness"
"2390","decreased attention"
"2391","uterine fibroid measurement"
"2392","CCL13 measurement"
"2393","CCL15 measurement"
"2394","CCL17 measurement"
"2395","CCL19 measurement"
"2396","CCL21 measurement"
"2397","CCL23 measurement"
"2398","CCL24 measurement"
"2399","CX3CL1 measurement"
"2400","CXCL12 measurement"
"2401","CXCL13 measurement"
"2402","CXCL5 measurement"
"2403","CXCL6 measurement"
"2404","interleukin 1 alpha measurement"
"2405","Eczema"
"2406","respiratory system disease"
"2407","beta-lactam allergy measurement"
"2408","household income"
"2409","social deprivation"
"2410","back pain"
"2411","pathological complete response"
"2412","gestational blood glucose measurement"
"2413","foot muscle strength measurement"
"2414","visual perception measurement"
"2415","visceral:total adipose tissue ratio"
"2416","age at diagnosis"
"2417","fragile X syndrome"
"2418","radiation-induced brain injury"
"2419","small intestine enteropathy"
"2420","brain infarction"
"2421","anterior uveitis"
"2422","cesarean section"
"2423","autoimmune type 1 diabetes"
"2424","idiopathic type 1 diabetes"
"2425","fulminant type 1 diabetes"
"2426","eye colour measurement"
"2427","healthspan"
"2428","peak expiratory flow"
"2429","alanine measurement"
"2430","asparagine measurement"
"2431","glycine measurement"
"2432","glutamine measurement"
"2433","histidine measurement"
"2434","leucine measurement"
"2435","methionine measurement"
"2436","proline measurement"
"2437","serine measurement"
"2438","threonine measurement"
"2439","ornithine measurement"
"2440","citrulline measurement"
"2441","Nasal cavity polyp"
"2442","tri-iodothyronine measurement"
"2443","tri-iodothyronine/thyroxine ratio measurement"
"2444","progesterone-receptor positive breast cancer"
"2445","progesterone-receptor negative breast cancer"
"2446","HER2 negative breast carcinoma"
"2447","carotid atherosclerosis"
"2448","central serous retinopathy"
"2449","remission"
"2450","total hip arthroplasty"
"2451","carpal tunnel syndrome"
"2452","neutropenia"
"2453","chromosomal aberration frequency"
"2454","chromosome-type aberration frequency"
"2455","chromatid-type aberration frequency"
"2456","treatment resistant depression"
"2457","frontal fibrosing alopecia"
"2458","lichen planopilaris"
"2459","ruminative stress response"
"2460","brooding stress response"
"2461","reflective stress response"
"2462","carbamazepine-induced hyponatremia"
"2463","oxcarbazepine-induced hyponatremia"
"2464","response to oxcarbazepine"
"2465","facial attractiveness measurement"
"2466","vesicoureteric reflex"
"2467","sum of basophil and neutrophil counts"
"2468","platelet-to-lymphocyte ratio"
"2469","neutrophil-to-lymphocyte ratio"
"2470","magnesium:creatinine ratio measurement"
"2471","fractional excretion of magnesium measurement"
"2472","activities of daily living score measurement"
"2473","mid-arm muscle circumference measurement"
"2474","calf circumference measurement"
"2475","short physical performance battery score measurement"
"2476","sleep apnea measurement during REM sleep"
"2477","sleep apnea measurement during non-REM sleep"
"2478","immunosuppressive agent"
"2479","cannabis dependence measurement"
"2480","tacrolimus measurement"
"2481","response to mepolizumab"
"2482","pregnancy induced alloimmunization"
"2483","colorectal health"
"2484","glucagon measurement"
"2485","glucose-dependent insulinotropic peptide (GIP) measurement"
"2486","glucagon-like peptide-1 measurement"
"2487","lateral ventricle volume measurement"
"2488","osteoarthritis of the hip"
"2489","Matrix Metalloproteinase 8 Measurement"
"2490","tryptophan measurement"
"2491","post-traumatic stress disorder symptom measurement"
"2492","anti-centromere-antibody-positive systemic scleroderma"
"2493","anti-topoisomerase-I-antibody-positive systemic scleroderma"
"2494","cholangiocarcinoma"
"2495","esterified cholesterol measurement"
"2496","free cholesterol measurement"
"2497","high density lipoprotein particle size measurement"
"2498","low density lipoprotein particle size measurement"
"2499","very low density lipoprotein particle size measurement"
"2500","intermediate density lipoprotein measurement"
"2501","chylomicron measurement"
"2502","acute respiratory distress syndrome"
"2503","psychological measurement"
"2504","negative domain measurement"
"2505","positive domain measurement"
"2506","cognitive domain measurement"
"2507","arousal domain measurement"
"2508","social domain measurement"
"2509","age at first birth measurement"
"2510","number of children ever born measurement"
"2511","theory of mind measurement"
"2512","seborrheic dermatitis"
"2513","adrenal suppression measurement"
"2514","myopic maculopathy severity measurement"
"2515","neurofilament light chain measurement"
"2516","beta-secretase 1 measurement"
"2517","response to synacthen"
"2518","rosacea severity measurement"
"2519","growth differentiation factor 15 measurement"
"2520","psychotic symptom measurement"
"2521","empathy measurement"
"2522","dead"
"2523","hyperemesis gravidarum"
"2524","response to aripiprazole"
"2525","maximum cigarettes per day measurement"
"2526","nicotine withdrawal symptom count"
"2527","nicotine dependence symptom count"
"2528","nausea and vomiting of pregnancy severity measurement"
"2529","refractory celiac disease"
"2530","family history of Alzheimer’s disease"
"2531","ADAMTS13 measurement"
"2532","heel bone mineral density"
"2533","Epstein Barr virus nuclear antigen-1 seropositivity"
"2534","Epstein Barr viral capsid antigen seropositivity"
"2535","anti-Epstein Barr virus antibody measurement"
"2536","Epstein Barr viral capsid antigen IgG measurement"
"2537","supraventricular ectopy"
"2538","ventricular ectopy"
"2539","premature cardiac contractions"
"2540","cranial vault morphology measurement"
"2541","response to tenofovir"
"2542","choroidal thickness measurement"
"2543","sodium measurement"
"2544","potassium measurement"
"2545","chloride measurement"
"2546","fractional shortening"
"2547","heart relative wall thickness"
"2548","posterior wall thickness"
"2549","left ventricular mass"
"2550","left ventricular mass index"
"2551","fructosamine measurement"
"2552","percent glycated albumin"
"2553","total glycated albumin"
"2554","atazanavir measurement"
"2555","response to long-chain n-3 PUFA dietary supplementation"
"2556","Hirsutism"
"2557","uveitis"
"2558","diabetic macular edema"
"2559","proliferative diabetic retinopathy"
"2560","cerebral cortex growth measurement"
"2561","prefrontal cortex growth measurement"
"2562","white matter growth measurement"
"2563","basal ganglia growth measurement"
"2564","cerebellum growth measurement"
"2565","brain growth measurement"
"2566","executive function measurement"
"2567","Chlamydia trachomatis seropositivity"
"2568","erosive tooth wear measurement"
"2569","APOL1 risk genotype carrier status"
"2570","alpha synuclein measurement"
"2571","velopharyngeal dysfunction"
"2572","Duchenne muscular dystrophy"
"2573","thyroid nodule"
"2574","Epstein-Barr virus early antigen seropositivity"
"2575","Herpes simplex virus 2 seropositivity"
"2576","Varicella zoster virus seropositivity"
"2577","Helicobacter pylori seropositivity"
"2578","Measles virus seropositivity"
"2579","Mumps virus seropositivity"
"2580","Rubella virus seropositivity"
"2581","Hepatitis B virus surface antigen seropositivity"
"2582","Hepatitis B virus core antigen seropositivity"
"2583","Anti-cytomegalovirus IgG measurement"
"2584","Anti-Epstein-Barr virus early antigen IgG measurement"
"2585","Anti-herpes simplex virus 1 IgG measurement"
"2586","Anti-herpes simplex virus 2 IgG measurement"
"2587","Anti-varicella zoster virus IgG measurement"
"2588","Anti-Helicobacter pylori IgG measurement"
"2589","Anti-Toxoplasma gondii IgG measurement"
"2590","Anti-influenza A virus IgG measurement"
"2591","Anti-measles virus IgG measurement"
"2592","Anti-mumps virus IgG measurement"
"2593","Anti-rubella virus IgG measurement"
"2594","Anti-hepatitis B virus surface antigen IgG measurement"
"2595","Anti-hepatitis B virus core antigen IgG measurement"
"2596","eyelid sagging measurement"
"2597","vulvovaginitis"
"2598","chronic central serous retinopathy"
"2599","non-allergic rhinitis"
"2600","vaginal discharge"
"2601","radon exposure measurement"
"2602","quality of life during menstruation measurement"
"2603","glucose metabolism measurement"
"2604","factor VII activating protease measurement"
"2605","diffusing capacity of the lung for carbon monoxide"
"2606","ketogenic diet"
"2607","response to ketogenic diet"
"2608","edema"
"2609","diverticulitis"
"2610","sum of eosinophil and basophil counts"
"2611","granule cell layer dentate gyrus volume"
"2612","hippocampal fissure volume"
"2613","parasubiculum volume"
"2614","arthritis disease activity score measurement"
"2615","offspring survival measurement"
"2616","offspring mortality measurement"
"2617","number of pregnancies measurement"
"2618","multiple births measurement"
"2619","age at last pregnancy measurement"
"2620","Waldenstrom macroglobulinemia"
"2621","BRCAX breast cancer"
"2622","diverticular disease"
"2623","Insulinogenic index measurement"
"2624","pneumococcal meningitis"
"2625","response to radioiodine"
"2626","bipolar I disorder"
"2627","bipolar II disoder"
"2628","Schizoaffective disorder-bipolar type"
"2629","candidemia"
